Tivozanib Non-Oncology Buy-Back Gives Quick Cash To AVEO

 
• By Ian Haydock
  
Kidney cancer
AVEO To Focus On Tivozanib In Renal And Other Cancers • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business